Diabetes

A collaborative clinic could save more than $5000 per patient over 3 years.

Genetics that determine physical traits may play a large role in prevalence of conditions such as multiple sclerosis, autism, and diabetes.

This article will highlight several key therapeutics areas with lixisenatide that every pharmacist should know.

The first of 4 new clinical trial of artificial pancreas systems has begun, which could benefit patients with type 2 diabetes.

Chronic exposure to air pollution may have a wide-reaching impact on children’s health.

Young individuals with type 2 diabetes are more likely to develop condition-related complications than their type 1 counterparts.

Liraglutide reduced the risk of type 2 diabetes by 80%.

Senior Executives with Insulet Corporation recently announced their milestone of achieving 100,000 active users worldwide of the Omnipod® Insulin Management System.

Some patients may not benefit from strict blood sugar control.

When patients are diagnosed with type 2 diabetes, clinicians stress lifestyle modifications—and especially diet—as the first and best intervention.

Patients with type 2 diabetes more likely to experience signs of kidney, nerve, and eye diseases.

Improved blood glucose control was elicited from the transplantation of reprogrammed pancreatic cells.

MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

Fixed-dose combination provides another oral treatment option for patients with diabetes.

Qtern is indicated to lower blood glucose levels in patients with type 2 diabetes.

The FDA has approved AstraZeneca’s fixed-dose combination drug, Qtern (10 mg dapagliflozin and 5 mg saxagliptin), for the treatment of type 2 diabetes as an adjunct to diet and exercise.

Long-term sitting may not impact diabetes risk as much as previously believed.

More than half of adults with type 2 diabetes are unaware they are at an increased risk of heart disease.

Top news of the day from across the health care landscape.

The use of MTM is expanding in the world of pharmacy. This article gives you a quick idea on what to screen for and address when analyzing a diabetic patients medication profile.

The American Diabetes Association (ADA) released their first position statement in 15 years regarding diabetic retinopathy.

Abdominal adiposity seen to increase the risk of type 2 diabetes, coronary heart disease, and cardiovascular risk factors.

Cost, forgetfulness, and complicated medication regimens drive poor patient antidiabetic medication adherence.

PCSK9 variants that lower cholesterol found to increase the risk of type 2 diabetes.

Few studies have examined the importance of socioeconomic risk factors on overall health.